Fresenius Medical Care AG
FMS24.985USD
-0.085-0.34%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
7.33BMarktkapitalisierung
10.26KGV TTM
mehr Informationen über Fresenius Medical Care AG Unternehmen
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Unternehmensinformationen
Unternehmens-codeFMS
Name des UnternehmensFresenius Medical Care AG
IPO-datumOct 02, 1996
Gegründet am2006
CEODr. Katarzyna Mazur-Hofsaess
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeOct 02
AddresseElse-Kroener-Strasse 1
StadtBAD HOMBURG VOR DER HOHE
BörseTSX Venture Exchange (former Canadian Ventures Exchange)
LandGermany
Postleitzahl61352
Telefon4961726090
Websitehttps://www.freseniusmedicalcare.com/
Unternehmens-codeFMS
IPO-datumOct 02, 1996
Gegründet am2006
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Stefanie Balling
Ms. Stefanie Balling
Vice Chairman of the Supervisory Board
Vice Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Ralf Erkens
Mr. Ralf Erkens
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Thu, Feb 20
Währung: USDUpdate-Zeit: Thu, Feb 20
FY2022
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
North America
14.27B
69.95%
Rest of the world
5.62B
27.54%
Germany
512.41M
2.51%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Aktionärsstatistik
Aktionäre
Anteil
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
5.01%
Investment Advisor
2.07%
Hedge Fund
0.32%
Research Firm
0.07%
Family Office
0.01%
Other
92.52%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
321
44.02M
7.50%
-2.98M
2024Q4
337
43.96M
7.49%
-3.12M
2024Q3
324
43.49M
7.41%
-1.75M
2024Q2
342
41.23M
7.03%
-8.59M
2024Q1
361
42.90M
7.31%
-5.86M
2023Q4
361
42.80M
7.29%
-6.45M
2023Q3
365
42.72M
7.28%
-7.66M
2023Q2
367
43.73M
7.45%
-13.55M
2023Q1
371
50.41M
8.59%
-15.36M
2022Q4
381
58.35M
9.94%
+10.96M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Pzena Investment Management, LLC
15.28M
2.6%
-932.64K
-5.75%
Dec 31, 2024
Wellington Management Company, LLP
8.20M
1.4%
--
--
Dec 31, 2024
Fiduciary Management, Inc.
6.31M
1.07%
-252.52K
-3.85%
Dec 31, 2024
Dodge & Cox
4.17M
0.71%
--
--
Dec 31, 2024
Aristotle Capital Management, LLC
1.16M
0.2%
--
--
Dec 31, 2024
Parametric Portfolio Associates LLC
973.20K
0.17%
+51.68K
+5.61%
Dec 31, 2024
Millennium Management LLC
722.24K
0.12%
+708.86K
+5.30K%
Dec 31, 2024
Integral Health Asset Management, LLC
600.00K
0.1%
+150.00K
+33.33%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
530.60K
0.09%
+76.80K
+16.92%
Dec 31, 2024
Janus Henderson Investors
528.22K
0.09%
+114.50K
+27.67%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
The Opal International Dividend Income ETF
1.67%
Cultivar ETF
1.49%
ActivePassive International Equity ETF
0.16%
Avantis Responsible International Equity ETF
0.04%
Avantis International Equity ETF
0.01%
Unusual Whales Subversive Republican Trading ETF
0%
Pacer Developed Markets International Cash Cws 100
0%
Inspire Fidelis Multi Factor ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Mehr Anzeigen
The Opal International Dividend Income ETF
Anteil1.67%
Cultivar ETF
Anteil1.49%
ActivePassive International Equity ETF
Anteil0.16%
Avantis Responsible International Equity ETF
Anteil0.04%
Avantis International Equity ETF
Anteil0.01%
Unusual Whales Subversive Republican Trading ETF
Anteil0%
Pacer Developed Markets International Cash Cws 100
Anteil0%
Inspire Fidelis Multi Factor ETF
Anteil0%
Unusual Whales Subversive Democratic Trading ETF
Anteil0%
DFA Dimensional International Core Equity 2 ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.94B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten